Automated External Defibrillators Market Growth, Size, Share & Future Outlook

[Research Report]The automated external defibrillator market size is projected to grow from US$ 1,556.21 million in 2022 to US$ 2,207.94 million by 2030; the market is estimated to record a CAGR of 4.5% from 2022 to 2030.

Market Insights and Analyst View:

A defibrillator is a device that gives a high-energy electric shock to the heart who is in cardiac arrest. This high-energy shock is called defibrillation, and it is an essential process to save the life of someone who is in cardiac arrest. The factors driving the market include the increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. However, performance issues related to automated external defibrillators are hindering the market growth.

Growth Drivers:

Rising Training and Awareness Programs on Automated External Defibrillators

In 2019, ~700,000 cases of out-of-hospital cardiac arrest (OHCA) happened in European countries and the US, with a significant proportion of these occurring at home and in public settings. The awareness regarding cardiopulmonary resuscitation (CPR) and automated external defibrillators (AED) is high in Western countries. A study titled “The Global Survival Rate among Adult Out-Of-Hospital Cardiac Arrest Patients who Received Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis,” published in 2020, assessed the survival rates of OHCA patients who received CPR from a bystander or emergency medical services and were living in a particular region. The study reported a significant rise in the survival rates from the OHCA in the past years, especially among patients who received CPR or AED and were living in Western countries. Furthermore, Shocktober is a global campaign that raises awareness and educates the community about CPR and AEDs. This campaign was initiated in October 2020 in Australia.

Online and offline training programs by organizations such as the WHO, US FDA, regional health centers, and local bodies have increased significantly across the globe. Various states in the US have enacted legislation to encourage the use of defibrillators and the availability of AEDs; they have also made provisions for educating and training people about the use and maintenance of AEDs. Further, the health authorities are creating a registry of locations where AEDs are present for public access. Several states have included the use of AEDs in the “good Samaritan” exemption from liability to promote its usage. The Good Samaritan law gives legal protection to the good samaritans who help accident victims with emergency medical care within the “Golden Hour.” For instance, in the UK, a training program was introduced by the Advanced Coronary Treatment (ACT) Foundation for secondary school students in association with British Columbia Emergency Health Services (BCEHS) in 2019. More than 4,000 students will be empowered by their teachers with crucial lifesaving skills every year. Paramedic volunteers train teachers to educate students at BCEHS. In certain universities, BCEHS is planning to implement defibrillator training as a part of the physical education curriculum. The British Heart Foundation’s “Nation of Lifesavers—Call, Push, Rescue” is another example of a simplified training program that focuses on compression-only CPR and AED. The British Heart Foundation has also taken the lead in rallying medical professionals to support public education in the UK. In 2020, during Denmark's opening Euro 2020 match, Christian Eriksen, a famous footballer, suffered from OHCA, which was one of the incidents that boosted awareness about the disease and the adoption of defibrillators at various locations; the use of defibrillators helped paramedics teams save the player’s life. Therefore, rising training and awareness programs on automated external defibrillators boost the automated external defibrillator market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Automated External Defibrillators Market: Strategic Insights

Automated External Defibrillators Market

• 
  CAGR (2022 - 2030)

  4.5%
• Market Size 2022
  US$ 1.56 Billion
• Market Size 2030
  US$ 2.21 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Shenzhen Mindray Bio-Medical Electronics Co Ltd
• Stryker Corp
• BPL Medical Technologies Pvt Ltd
• Schiller AG
• Mediana Co Ltd
• Nihon Kohden Corp
• Asahi Kasei Corp
• CU Medical Systems Inc
• Progetti SRL
• Koninklijke Philips NV

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Fully-automated External Defibrillators and Semi-automated External Defibrillators

End User

• Hospitals & Clinics
•  Homecare
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Report Segmentation and Scope:

In terms of type, the global automated external defibrillator market is segmented into fully-automated external defibrillators and semi-automated external defibrillators. The fully-automated external defibrillators segment held a larger market share in 2022 and the same segment is expected to retain its dominant position over the forecast period (2022–2030).

By end user, the automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. In 2022, the hospitals & clinics segment held the largest market share, and the homecare segment is estimated to record the fastest CAGR of 5% from 2022 to 2030.

Segmental Analysis:

In terms of type, the global automated external defibrillator market is segmented into fully-automated external defibrillators and semi-automated external defibrillators. The fully-automated external defibrillators segment held a larger market share in 2022 and the same segment is expected to retain its dominant position over the forecast period (2022–2030. The difference between the FAED and semi-automated external defibrillators (SAED) is that an FAED unit delivers a shock without human intervention, and an SAED requires a user to push the actual shock button. Semi-automated defibrillators monitor the heart's rhythm. This type of AED will still automatically monitor the heart rhythm and decide when a shock is necessary, including checking heart rhythm to see if additional shocks are needed.

A lay responder can use a fully automatic external defibrillator (FAED) to treat someone who has gone into cardiac arrest. In FAEDs, the user does not need to press any buttons to provide the shock; the device analyzes itself, and if a shock is required, the device administers it without the need for anyone to press a button. The user activates the FAED by pressing a button or opening the lid. The user unfolds the pads and places them on the patient as directed by the illustrations on the pads. The FAED analyzes the patient's heart rhythm once the pads are in place to see if a shock is required. If a shock is required, the FAED notifies and gives a shock to the patient without the help of any individual to push the shock button.

Automated External Defibrillator Market, by Type – 2022 and 2030

Access Data

By end user, the automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. In 2022, the hospitals & clinics segment held the largest market share, and the homecare segment is estimated to record the fastest CAGR of 5% from 2022 to 2030Hospitals and clinics are the largest entities that have all the facilities available. Hospitals and clinics also provide several diagnostics and treatment facilities that can be reimbursed in case of insurance claims. Hospitals have all the required equipment and instruments, such as defibrillators. Due to the development of healthcare facilities, hospitals are upgraded with modernized equipment and are integrated with artificial intelligence. These developments assist in inter-department communication and perform auto procedures with precision. Hospitals have general doctors, specialists, and other medical professionals who provide better healthcare services. The rise in cardiac arrest cases drives the market for the hospitals & clinics segment. Moreover, the rise in the number of cardiac implant procedures and the availability of reimbursements in developed markets are driving the market growth for the hospitals & clinics segment.

Regional Analysis:

By geography, the global automated external defibrillator market is segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2022, North America contributed the largest share of the global automated external defibrillator market size. Asia Pacific is anticipated to register the highest CAGR during the forecast period.

The automated external defibrillator market in North America is categorized into the US, Canada, and Mexico. The US is the largest market for automated external defibrillators. The market is prominently driven by an extensive rise in respiratory diseases, a big pool of diabetic population, and an increase in awareness about respiratory diseases among the population. The US is projected to be the largest market for automated external defibrillators due to multiple factors such as an increase in the incidence of cardiovascular disease (CVDs), rising awareness about the presence of automatic defibrillators, the presence of leading pharmaceutical companies in this region, and the existence of fully developed healthcare infrastructure. Moreover, technological advancements have resulted in the development of various novel defibrillators.

Coronary artery disease (CAD) is among the leading causes of morbidity and mortality in many developed countries. According to the Centers for Disease Control research, CAD accounts for ~6,10,000 deaths annually (estimated 1 in 4 deaths), which makes it the leading cause of death in the US. Furthermore, the population of people aged 65 and above is predicted to increase between 2012 and 2050, which boosts the need for a greater understanding of the impact of cardiovascular diseases on older adults.

In addition, the rising prevalence of cardiac conditions among people contributes to the automated external defibrillator market growth. Per the American Heart Association's (AHA) "heart disease and Stroke Statistics 2019,” approximately 121 million adults in the US are suffering from CVDs, and every year—8,05,000 Americans suffer from a heart attack. In addition, as per the CDC, ~7,95,000 people in the US suffer from cerebrovascular stroke every year. As per DIL—a Conversational Agent for Heart Failure Patients by Claremont Graduate University published in 2019—the indirect and direct costs associated with the treatment of cardiovascular diseases and stroke are anticipated to be more than US$ 329.7 billion, which includes both health expenditures and productivity loss. Therefore, the cost of the treatments increases for the patients.

Hypertension is considered one of the major risk factors for heart diseases, strokes, and cardiac arrests, but it is highly treatable. According to a 2023 report from the American Heart Association, approximately 50% of Americans aged 20 years and above, i.e., more than 122 million people, have high blood pressure. The prevalence of hypertension is expected to rise in the coming years; therefore, it is anticipated that the incidences of cardiovascular diseases are also likely to increase in the coming years.

Industry Developments and Future Opportunities:

Various initiatives taken by leading players operating in the automated external defibrillator market are listed below:

1. In April 2020, Philips continued to comply with the terms of the consent decree by the FDA, which remains in effect and includes ongoing regulatory compliance monitoring and facility inspections of the ECR business and the company’s other patient care businesses. The business resumed manufacturing and shipping of external defibrillators for the US following an alert from the FDA that the injunction prohibiting those activities has been lifted.
2. In October 2023, The Murcia Health Service took a step towards improving medical care for patients with palpitations, arrhythmias, and strokes by acquiring 80 state-of-the-art Holters linked to a web server that allowed cardiologists to interpret and read these examinations from any location, automatically integrating the results into the electronic patient record.
3. In June 2023, Shenzhen Mindray Bio-Medical Electronics Co Ltd announced an agreement to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH from Gorka Holding GmbH, through Mindray Medical Netherlands BV—a wholly-owned subsidiary of Mindray’s wholly-owned subsidiary MR Global (HK) Ltd—for an all-cash preliminary purchase price of approximately EUR 115 million (USD 123 million).
4. In May 2023, Shenzhen Mindray Bio-Medical Electronics Co Ltd signed a strategic agreement with Vithas. Under the agreement, Vithas integrated the latest innovative patient monitoring technology across its 20 hospitals. The strategic partnership enabled Vithas to improve patient safety in critical areas such as ICUs, operating rooms, and post-anesthesia recovery and emergency units.

Furthermore, CVDs have been among the leading causes of death in countries such as India, China, and Brazil. With the rising cases of cardiovascular diseases in regions such as Asia Pacific and South & Central America, the automated external defibrillator market players have started to or are expected to strategize their growth in these regions. Companies such as Abbott, Medtronic, Asahi Kasei (ZOLL), and Biotronik are expected to continue growing in these emerging markets through mergers, acquisitions, and strategic partnerships in the coming years. In April 2020, Medtronic invested and relaunched the Medtronic Engineering and Innovation Center (MEIC) in Hyderabad, India. The company has invested US$ 160 million to expand the MEIC, which initially opened in 2011. Medtronic also invested over US$ 50 million in its manufacturing facilities in Puerto Rico. The company is considered to be a primary job provider in Puerto Rico, and the investment shows the company’s resolve to expand further in the emerging region.

Competitive Landscape and Key Companies:

Shenzhen Mindray Bio-Medical Electronics Co Ltd, Stryker Corp, BPL Medical Technologies Pvt Ltd, Schiller AG, Mediana Co Ltd, Nihon Kohden Corp, Asahi Kasei Corp, CU Medical Systems Inc, Progetti SRL, and Koninklijke Philips NV are the prominent automated external defibrillator market companies. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the growing consumer demand worldwide.

Automated External Defibrillators Market Report Scope